Inotek Pharmaceuticals Corporation Announces Changes To Board Of Directors

LEXINGTON, Mass.--(BUSINESS WIRE)--Inotek Pharmaceuticals Corporation (NASDAQ:ITEK), a clinical stage biopharmaceutical company focused on the discovery, development and commercialization of therapies for ocular diseases, today announced that J. Martin Carroll has been elected to its Board of Directors and that Mr. Carroll has been elected Chairperson of the Board effective as of the 2016 Annual Meeting. The meeting is scheduled to take place on June 23, 2016. Mr. Carroll will succeed Argeris Karabelas, Ph.D., as Chairperson.

Back to news